The pharmaceutical industry is constantly seeking efficient and cost-effective sourcing solutions for essential drug intermediates. For companies involved in the production of Decitabine, understanding the market dynamics for 1-Chloro-3,5-di(4-chlorobenzoyl)-2-deoxy-D-ribose (CAS: 3601-90-9) is vital. This article provides insights into the pricing, availability, and key considerations when looking to purchase this critical compound.

1-Chloro-3,5-di(4-chlorobenzoyl)-2-deoxy-D-ribose is a high-value intermediate crucial for Decitabine synthesis, a drug used in treating myelodysplastic syndromes. The global demand for Decitabine directly influences the market for its precursors. As a leading supplier in China, we aim to provide competitive price points and ensure a consistent supply to meet the manufacturing needs of our clients. Factors such as raw material costs, production scale, and global logistics all play a role in the final pricing and availability of this intermediate.

When you decide to buy 1-Chloro-3,5-di(4-chlorobenzoyl)-2-deoxy-D-ribose, it is essential to partner with a reputable manufacturer that can guarantee both quality and quantity. Our production processes are optimized to deliver a product with a purity of ≥98.0% (HPLC), ensuring suitability for pharmaceutical applications. We actively monitor market trends to offer the best possible pricing while maintaining the highest quality standards. Understanding lead times and minimum order quantities is also critical for effective planning.

For procurement managers, proactively engaging with suppliers and requesting quotes is the best approach to secure favorable terms. The reliability of a supplier is as important as the price. A consistent supply chain, backed by strong quality control and efficient logistics, is essential for uninterrupted Decitabine production. We are dedicated to being that reliable partner, offering transparent pricing and readily available stock for businesses worldwide. Reach out to us to discuss your specific needs and to get the latest market insights on this vital pharmaceutical intermediate.